Acknowledgements
The authors were supported by a National Health and Medical Research Council (NHMRC) Program Grant (ID: 566529). ARY was supported by a NHMRC Senior Research Fellowship (ID: 566593). CP was supported by a NHMRC Senior Principal Research Fellowship (ID: 628386).
In the last 5 years, ARY has received Honoraria from Eli Lilly, Bristol Myer Squibb, and Janssen-Cilag. PDM has received Honoraria from Eli Lilly, Janssen-Cilag, Pfizer, and Astra Zeneca. ARY and PDM are investigators on an Investigator Initiated study of the at risk group funded by Astra Zeneca. CP has received grant support from Janssen-Cilag, Eli Lilly, Hospira (Mayne), and Astra Zeneca, and has provided consultancy to Janssen-Cilag, Eli Lilly, Hospira (Mayne), Astra Zeneca, Pfizer, Schering Plough, and is an investigator on an Investigator Initiated study of bipolar disorder funded by Astra Zeneca. SJW has no disclosures.